Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2857 Target Snapshot

Human rhinovirus A protease · SINGLE PROTEIN · Human rhinovirus sp.

812Compounds
266Assays
2Approved Drugs
684.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt Q4U254. Use UniProt Q4U254 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q4U254 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Human rhinovirus A protease as ChEMBL target CHEMBL2857, mapped to UniProt Q4U254. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Human rhinovirus A protease
SINGLE PROTEIN · Human rhinovirus sp.
As of 2026-09-13
ChEMBL target ID
CHEMBL2857
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q4U254
Genome polyprotein
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Human rhinovirus A protease is the right protein anchor across sources, using UniProt Q4U254 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelGenome polyprotein
UniProt AccessionQ4U254
Component TypeProtein
Sequence Length401 aa

Genome polyprotein

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Human rhinovirus A protease, mapped to UniProt Q4U254. ChEMBL maps the protein component as Genome polyprotein. Sequence length is 401 aa.

Mapped IDQ4U254
Review nameHuman rhinovirus A protease
OrganismHuman rhinovirus sp.
Clinical Profile

Clinical Phase Distribution

2
Approved
1
Phase III
7
Phase II
Assay Mix

Activity Type Distribution

IC50327.0
KI203.0
EC50154.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL13134 9.89 Ki 0.13 Clinical
CHEMBL17612 9.62 IC50 0.24 Preclinical
CHEMBL114 9.3 IC50 0.5 Approved
CHEMBL279448 9.0 EC50 1.0 Preclinical
CHEMBL291277 9.0 EC50 1.0 Preclinical
CHEMBL304086 8.92 Ki 1.2 Preclinical
CHEMBL117484 8.7 Ki 2.0 Preclinical
CHEMBL289920 8.7 EC50 2.0 Preclinical
CHEMBL267571 8.64 IC50 2.3 Preclinical
CHEMBL145830 8.52 Ki 3.0 Preclinical
Distribution

pChEMBL Value Distribution

84
5.0
85
5.5
97
6.0
68
6.5
56
7.0
41
7.5
32
8.0
10
8.5
3
9.0
3
9.5
pChEMBL
Approved Drugs

Approved Drugs

SAQUINAVIR
CHEMBL114
Approved 1995
HALOPERIDOL
CHEMBL54
Approved 1967
Assay Landscape

Assay Landscape

267
Total Assays
422
Tested Compounds
2
Assay Types
Binding — 198 assays, 422 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 174 360 6.1
assay format 13 56 6.1
cell-based format 11 6 7.1
Functional — 69 assays, 66 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 63 48 6.8
cell-based format 5 18 5.3
organism-based format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine